热门资讯> 正文

Enveric Biosciences GAAP每股收益为-0.76美元

2026-08-17 16:10

Enveric Biosciences, Inc.(ENVB) 0

Enveric Biosciences press release (ENVB): Q2 GAAP EPS of -$0.76.
The company had cash-on-hand of $8.3 million as of June 30, 2026. For the quarter ended June 30, 2026, the company raised gross proceeds of $5.0 million through offerings and $1.5 million from the exercise of warrants.

More on Enveric Biosciences

Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026
Historical earnings data for Enveric Biosciences
Financial information for Enveric Biosciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。